Immediate Impact
22 from Science/Nature 62 standout
Citing Papers
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
Zwitterionic Biomaterials
2022 Standout
Works of J. C. Yao being referenced
A phase II study of irinotecan and cisplatin for metastatic or unresectable high grade neuroendocrine carcinoma
2008
Suppression of Osteoblast Function by Titanium Particles* **
1997
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| J. C. Yao | 168 | 132 | 296 | 178 | 24 | 902 | |
| B Schneider | 249 | 125 | 284 | 188 | 29 | 1.0k | |
| Takahiro Sakuma | 79 | 184 | 294 | 290 | 36 | 1.0k | |
| Christian August | 96 | 58 | 306 | 306 | 42 | 902 | |
| Hans Olivecrona | 121 | 101 | 175 | 199 | 34 | 793 | |
| Michael E. Rosenfeld | 85 | 186 | 157 | 234 | 26 | 968 | |
| Cinzia Manuelli | 127 | 89 | 121 | 242 | 30 | 1.1k | |
| R. Burt | 138 | 98 | 213 | 166 | 25 | 767 | |
| Yancheng Song | 166 | 172 | 183 | 199 | 52 | 854 | |
| Marian Sturm | 115 | 90 | 256 | 195 | 28 | 875 | |
| Nils Hansen‐Algenstaedt | 75 | 109 | 358 | 197 | 41 | 825 |
All Works
Loading papers...